logo
logo

Oncimmune's cancer test diagnoses '80pc of tumours' early, saving lives

avatar
Jeffrey Zambrana
img

Tweet us at @TelegraphTech with your suggestions.

Currently, the UK s National Health Service NHS is conducting on of the largest lung cancer screening efficacy trial on 12,000 people, to find out how much money it could save by screening high risk smokers with the Oncimmune test.

The European IPO winter

It s been a particularly barren quarter for European IPOs.

Startups are going public later in the cycle because of the glut of private money.

It's not just to raise capital, but also to raise its profile to attract new institutional customers, Hamilton–Fairley says.

This week, it announced it had signed up three new US distributors for its lung cancer test.

collect
0
avatar
Jeffrey Zambrana
guide
Zupyak is a free content platform for publishing and discovering stories, software and startups.